MTFB Motif Bio plc

0.8
0  0%
Previous Close 0.8
Open
Price To Book -1.54
Market Cap 13,703,066
Shares 17,124,551
Volume 10,000
Short Ratio
Av. Daily Volume 124,378

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL issued February 14, 2019. Noted June 6, 2019 that further trials are required.
Iclaprim
Acute bacterial skin and skin structure infections (ABSSSI)
Phase 3 data released April 18, 2017 - primary endpoint of non-inferiority met.
Iclaprim -REVIVE-1
Acute bacterial skin and skin structure infections (ABSSSI)

Latest News

  1. Antimicrobials Working Group Commends Senator Isakson and Senator Casey for Introducing Legislation to Improve Access to Innovative Therapies to Fight Drug-Resistant Infections
  2. Motif Bio Announces Path Forward for Iclaprim following Receipt of FDA Meeting Minutes
  3. Result of Annual General Meeting
  4. Motif Bio plc AGM Statement
  5. Motif Bio to Evaluate Orphan Disease Opportunity for Iclaprim in Ophthalmology
  6. Motif Bio to Present Iclaprim Data at ASM Microbe 2019
  7. Motif Bio meeting with U.S. FDA held as planned
  8. Motif Bio Signs Agreement with Lamellar Biomedical
  9. Motif Bio plc: Notice of Annual General Meeting
  10. Motif Bio Announces Appointment of Andrew Powell to Board of Directors
  11. The Daily Biotech Pulse: J&J Earnings, FDA Nod For Medicinova, Proteon To Explore Strategic Alternatives
  12. Motif Bio Presents New Iclaprim Data at ECCMID 2019
  13. Motif Bio Reports Fiscal Year 2018 Results
  14. Antimicrobials Working Group Highlights Member Company Participation at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
  15. Motif Bio to Present Iclaprim Data at ECCMID 2019
  16. The Daily Biotech Pulse: FDA Nod For Sage's Postpartum Depression Drug, Pfizer Invests In Gene Therapy Company
  17. Motif Bio Granted Meeting with U.S. FDA regarding Iclaprim
  18. Motif Bio Announces Appointment of Bruce Williams as Interim Chairman and Resignation of Richard Morgan from the Board
  19. MTFB: FDA Issues CRL for Iclaprim…
  20. Motif Bio Conference Call and Webcast